{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:55:45Z","timestamp":1781528145961,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.msard.2026.107138","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:32:22Z","timestamp":1773361942000},"page":"107138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Divergent comorbidity profiles in neuromyelitis optica spectrum disorder and multiple sclerosis: A large single-centre cohort from Turkey"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9003-7066","authenticated-orcid":false,"given":"Ergi","family":"Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8168-3568","authenticated-orcid":false,"given":"Can","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3086-8102","authenticated-orcid":false,"given":"Zuhal","family":"Abas\u0131yan\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2140-4103","authenticated-orcid":false,"given":"Serkan","family":"Ozakbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107138_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120460","article-title":"Predictors of overlapping autoimmune disease in Neuromyelitis Optica Spectrum disorder (NMOSD): a retrospective analysis in two inner-city hospitals","volume":"443","author":"Alvarez","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2026.107138_bib0002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458517699791","article-title":"Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: a predominantly population-based study","volume":"24","author":"Asgari","year":"2018","journal-title":"Mult Scler J"},{"key":"10.1016\/j.msard.2026.107138_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104852","article-title":"Epidemiologic and clinical characteristics of neuromyelitis optica spectrum disorder patients, A seven years follow-up study from Iran","volume":"77","author":"Ashtari","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"14","key":"10.1016\/j.msard.2026.107138_bib0004","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1177\/13524585251356820","article-title":"The cascade sign in aquaporin-4-IgG positive (AQP4-IgG+) NMOSD","volume":"31","author":"Bonan","year":"2025","journal-title":"Mult. Scler. J."},{"issue":"5","key":"10.1016\/j.msard.2026.107138_bib0005","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/jon.13137","article-title":"MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease","volume":"33","author":"Carnero Contentti","year":"2023","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.msard.2026.107138_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105519","article-title":"The risk of type 2 diabetes mellitus in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide cohort study","volume":"85","author":"Cho","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.msard.2026.107138_bib0007","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1177\/13524585221096964","article-title":"Acute myocardial infarction risk in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide cohort study in South Korea","volume":"28","author":"Cho","year":"2022","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2026.107138_bib0008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107138_bib0009","article-title":"Incidence of AQP4-IgG seropositive neuromyelitis optica spectrum disorders in the Netherlands: about one in a million","volume":"2","author":"Dani\u00eblle Van Pelt","year":"2016","journal-title":"Mult. Scler. J. - Exp. Transl. Clin."},{"issue":"1","key":"10.1016\/j.msard.2026.107138_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/1744666X.2016.1205486","article-title":"Behcet\u2019s disease: epidemiology, clinical manifestations, and diagnosis","volume":"13","author":"Davatchi","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2026.107138_bib0011","doi-asserted-by":"crossref","DOI":"10.31083\/j.jin2302035","article-title":"Systemic connective tissue disease and Neuromyelitis Optica spectrum disorder coexistence: a systematic review and meta-analysis","volume":"23","author":"Esposito","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.msard.2026.107138_bib0012","article-title":"Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder","volume":"427","author":"Exuzides","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107138_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102425","article-title":"Epidemiology and comorbidities of adult multiple sclerosis and neuromyelitis optica in Taiwan, 2001\u20132015","volume":"45","author":"Fang","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107138_bib0014","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.msard.2017.11.002","article-title":"Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina","volume":"19","author":"Fern\u00e1ndez","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107138_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105683","article-title":"Impact of comorbidities on relapsing rates of neuromyelitis optica spectrum disorders: insights from a longitudinal study in Taiwan","volume":"87","author":"Hsu","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2026.107138_bib0016","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00702-024-02792-0","article-title":"Depression and anxiety in multiple sclerosis. Review of a fatal combination","volume":"131","author":"Jellinger","year":"2024","journal-title":"J. Neural Transm."},{"issue":"14","key":"10.1016\/j.msard.2026.107138_bib0017","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/WNL.0b013e3182a6cb5c","article-title":"Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica","volume":"81","author":"Jiao","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2026.107138_bib0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","article-title":"Neurodegeneration in multiple sclerosis and neuromyelitis optica","volume":"88","author":"Kawachi","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.msard.2026.107138_bib0019","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200329","article-title":"Lupus myelitis\u201d revisited: a retrospective single-center study of myelitis associated with rheumatologic disease","volume":"12","author":"Krett","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflammat."},{"issue":"6","key":"10.1016\/j.msard.2026.107138_bib0020","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/13524585241237093","article-title":"Risk of depression and anxiety in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide cohort study in South Korea","volume":"30","author":"Kwon","year":"2024","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.msard.2026.107138_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5603\/pjnns.102908","article-title":"Herpes zoster prevention in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"59","author":"Mirowska-Guzel","year":"2025","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.msard.2026.107138_bib0022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2015.11.031","article-title":"Cognitive and psychiatric comorbidities in neuromyelitis optica","volume":"360","author":"Moore","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107138_bib0023","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.sleep.2018.05.039","article-title":"Systematic review and meta-analysis of observational studies to understand the prevalence of restless legs syndrome in multiple sclerosis: an update","volume":"50","author":"Ning","year":"2018","journal-title":"Sleep. Med."},{"issue":"12","key":"10.1016\/j.msard.2026.107138_bib0024","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1007\/s00415-024-12698-2","article-title":"Aquaporin4-IgG seropositivity significantly increases the risk of comorbid autoimmune diseases in NMOSD patients: population-based registry data","volume":"271","author":"Pekmezovic","year":"2024","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107138_bib0025","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10072-019-04230-6","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)","volume":"41","author":"Rojas","year":"2020","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.msard.2026.107138_bib0026","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70214","article-title":"Comorbidities are associated with unfavorable outcome in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: exploratory study from the <scp>CROCTINO<\/scp>cohort","volume":"32","author":"Samadzadeh","year":"2025","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107138_bib0027","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10067-023-06809-z","article-title":"Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren\u2019s syndrome","volume":"43","author":"Sami","year":"2024","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.msard.2026.107138_bib0028","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.msard.2018.07.011","article-title":"Cardiovascular conditions in persons with multiple sclerosis, neuromyelitis optica and transverse myelitis","volume":"25","author":"Saroufim","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"38","key":"10.1016\/j.msard.2026.107138_bib0029","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017184","article-title":"Comparison of psychiatric disturbances in patients with multiple sclerosis and neuromyelitis optica","volume":"98","author":"Shin","year":"2019","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.msard.2026.107138_bib0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.msard.2026.107138_bib0031","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrneurol.2011.176","article-title":"Longitudinal extensive transverse myelitis\u2014it\u2019s not all neuromyelitis optica","volume":"7","author":"Trebst","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2026.107138_bib0032","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S1474-4422(18)30311-9","article-title":"Comorbidities, treatment, and pathophysiology in restless legs syndrome","volume":"17","author":"Trenkwalder","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2026.107138_bib0033","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jneuroim.2010.11.010","article-title":"Enhanced complement consumption in neuromyelitis optica and Beh\u00e7et\u2019s disease patients","volume":"233","author":"T\u00fcz\u00fcn","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.msard.2026.107138_bib0034","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"Uzawa","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2026.107138_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102879","article-title":"Population-based head-to-head comparison of the clinical characteristics and epidemiology of AQP4 antibody-positive NMOSD between two European countries","volume":"51","author":"Viktoria","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2026.107138_bib0036","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2026.107138_bib0037","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4103\/1673-5374.179048","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases","volume":"11","author":"Yokote","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.msard.2026.107138_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.533388","article-title":"The role of antibodies in the pathogenesis of multiple sclerosis","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107138_bib0039","doi-asserted-by":"crossref","DOI":"10.20517\/2347-8659.2019.06","article-title":"Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences","volume":"2019","author":"Zhang","year":"2019","journal-title":"Neuroimmunol. Neuroinflammat."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:23:45Z","timestamp":1781526225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826001744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"alternative-id":["S2211034826001744"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107138","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergent comorbidity profiles in neuromyelitis optica spectrum disorder and multiple sclerosis: A large single-centre cohort from Turkey","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107138"}}